XML 26 R13.htm IDEA: XBRL DOCUMENT v3.22.1
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
3 Months Ended
Mar. 31, 2022
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS  
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

5. CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

The Company’s cash equivalents and short-term investments are invested in the following (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

March 31, 2022

​

    

Amortized Cost

    

Unrealized Gains

    

Unrealized Losses

    

Fair Value

Money market funds

​

$

87,581

​

$

—

​

$

—

​

$

87,581

Total cash equivalents

​

​

87,581

​

​

—

​

​

—

​

​

87,581

Commercial paper

​

​

56,282

​

​

—

​

​

—

​

​

56,282

Corporate bonds

​

​

16,140

​

​

—

​

​

(32)

​

​

16,108

Government bonds

​

​

17,274

​

​

—

​

​

(3)

​

​

17,271

Asset-backed securities

​

​

7,516

​

​

—

​

​

(2)

​

​

7,514

Total short-term investments

​

​

97,212

​

​

—

​

​

(37)

​

​

97,175

Total cash equivalents and short-term investments

​

$

184,793

​

$

—

​

$

(37)

​

$

184,756

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

December 31, 2021

​

    

Amortized Cost

    

Unrealized Gains

    

Unrealized Losses

    

Fair Value

Money market funds

​

$

46,521

​

$

—

​

$

—

​

$

46,521

Total cash equivalents

​

​

46,521

​

​

—

​

​

—

​

​

46,521

Commercial paper

​

​

70,401

​

​

—

​

​

—

​

​

70,401

Corporate bonds

​

​

65,645

​

​

—

​

​

(28)

​

​

65,617

Government bonds

​

​

36,487

​

​

—

​

​

(11)

​

​

36,476

Asset-backed securities

​

​

24,665

​

​

—

​

​

(10)

​

​

24,655

Total short-term investments

​

​

197,198

​

​

—

​

​

(49)

​

​

197,149

Total cash equivalents and short-term investments

​

$

243,719

​

$

—

​

$

(49)

​

$

243,670

​

During the year ended December 31, 2021, the Company made a $20.0 million investment in equity securities of a publicly-traded company. The Company records this investment at fair value, which was $5.7 million as of March 31, 2022. Prior to the investment, the Company entered into a subscription agreement to purchase the investment, resulting in a subscription agreement liability which was derecognized upon investment. During the three months ended March 31, 2022, the Company recorded an unrealized loss due to the change in fair value of the equity securities of $1.7 million in interest and other (expense) income, net in the consolidated statements of operations.